(Q33387197)

26 July 2017

title

Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome (English)

1 reference

26 July 2017

1 reference

Valderez Raposo de Mello

1

1 reference

26 July 2017

Maira Tinte Rodrigues

2

1 reference

26 July 2017

Tais Helena Mastrocinque

3

1 reference

26 July 2017

Simone Paiva Laranjo Martins

4

1 reference

26 July 2017

Olberes Vitor Braga de Andrade

5

1 reference

26 July 2017

Eliana Biondi Medeiros Guidoni

6

1 reference

26 July 2017

Daniel Kashiwamura Scheffer

7

1 reference

26 July 2017

Dino Martini Filho

8

1 reference

26 July 2017

Julio Toporovski

9

1 reference

26 July 2017

Vanda Benini

10

1 reference

26 July 2017

publication date

1 March 2010

1 reference

26 July 2017

1 reference

26 July 2017

volume

25

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

453-460

1 reference

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-009-1356-X

Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-009-1356-X

Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis

21 January 2018

1 reference

12 December 2020

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Enalapril and prednisone in children with nephrotic-range proteinuria

1 reference

12 December 2020

The use of mycophenolate mofetil in transplant recipients

1 reference

12 December 2020

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade

1 reference

12 December 2020

Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics

1 reference

12 December 2020

RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection

1 reference

12 December 2020

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.

1 reference

12 December 2020

Nephrotic syndrome in childhood.

1 reference

12 December 2020

The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.

1 reference

12 December 2020

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Use of mycophenolate mofetil in resistant membranous nephropathy.

1 reference

12 December 2020

Mycophenolate mofetil: a decade of clinical experience

1 reference

12 December 2020

Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity.

1 reference

12 December 2020

High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood

1 reference

12 December 2020

Mycophenolate mofetil treatment for primary glomerular diseases

1 reference

12 December 2020

Mycophenolate mofetil therapy for children with intractable nephrotic syndrome

1 reference

12 December 2020

Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study

1 reference

12 December 2020

Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study

1 reference

12 December 2020

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome

1 reference

12 December 2020

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

1 reference

12 December 2020

10.1007/S00467-009-1356-X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1023950620

0 references

1 reference